307 results on '"Fornai, M."'
Search Results
2. Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology
3. Anti-inflammatory effect of a novel locally acting A2A receptor agonist in a rat model of oxazolone-induced colitis
4. P033 The assessment of serum cytokines at baseline could predict mucosal healing in patients with Crohn's disease treated with ustekinumab. A prospective study
5. Author Correction: Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology.
6. OC.02.6 BASELINE IL-23 SERUM LEVELS PREDICT MUCOSAL HEALING IN PATIENTS WITH CROHN’S DISEASE TREATED WITH USTEKINUMAB. A PROSPECTIVE STUDY
7. Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
8. Allopurinol adherence among patients with gout: an Italian general practice database study
9. Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease
10. Role of the A2B receptor–adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats
11. Editorial: serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab—authors' reply
12. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage
13. Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice
14. T04.01.20 SERUM ONCOSTATIN M PREDICTS MUCOSAL HEALING IN CROHN'S DISEASE PATIENTS TREATED WITH INFLIXIMAB
15. Efficacy and Tolerability of Meloxicam, a COX-2 Preferential Nonsteroidal Anti-Inflammatory Drug: A Review
16. P454 Serum oncostatin M predicts mucosal healing in Crohn’s disease patients treated with infliximab
17. A1 and A2a receptors mediate inhibitory effects of adenosine on the motor activity of human colon
18. Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction
19. ENTERIC INFLAMMATION AND ALTERED COLONIC CHOLINERGIC NEUROTRANSMISSION IN A SPONTANEOUS MODEL OF ALZHEIMER'S DISEASE: TIMING FROM EARLY PHASES TO FULL DISEASE DEVELOPMENT
20. ANTI-INFLAMMATORY AND VISCERAL PAIN RELIEVING EFFECTS OF AR170, A POTENT AND SELECTIVE A3 RECEPTOR AGONIST, IN A RAT MODEL OF COLITIS
21. Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease
22. Cholecystokinin CCK2 receptors mediate the peptideʼs inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway
23. Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon
24. AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases
25. P.07.3 EARLY MEASUREMENT OF SERUM CYTOKINES AS PREDICTOR OF CLINICAL AND ENDOSCOPIC OUTCOME TO VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS
26. OC.05.3 HISTOMORPHOLOGICAL AND MOLECULAR CHARACTERIZATION OF PARKINSON'S DISEASE PATIENTS WITH CONSTIPATION: A PILOT STUDY
27. P709 Early measurement of serum cytokines as predictor of clinical and endoscopic outcome to vedolizumab in patients with ulcerative colitis
28. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats
29. Neuronal regulation of intestinal immune functions in health and disease
30. P060 Post-inflammatory visceral pain induced by DNBS: Preclinical features for novel therapeutics
31. Targeting of NLRP3 Inflammasome With a Novel Selective Inhibitor as a Suitable Strategy for the Pharmacological Treatment of Bowel Inflammation
32. 10.26 Acute Pressure Overload Induces Oxidative Stress and t-PA Expression in Rat Mesenteric Small Arteries
33. ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006
34. Acute Pressure Overload Induces Oxidative Stress and t-PA Expression in Rat Mesenteric Small Arteries
35. Cyclooxygenase inhibitors counteract pro-fibrotic signalling in experimental colitis through modulation of TGF-beta/SMAD network
36. Colonic inflammation in experimental Parkinson’s disease
37. Rifaximin prevents enteric bacteria alterations and inflammation in a rat model of diclofenac-induced enteropathy
38. Morpho-functional alterations of colonic neuromuscular compartment in experimental Parkinson’s disease
39. Role of adenosine A2B receptor in the control of inflammation, fibrosis and motility in experimental colitis
40. Modulatory role of adenosine A2B receptors in fibrotic gut wall remodeling associated with experimental colitis
41. Characterization of the Risk of Bleeding with Novel Oral Anticoagulants and Warfarin: A Pilot Case-Control Study
42. Role of P2X7 purinergic receptor in the control of enteric neuromuscular functions in normal rat distal colon and experimental bowel inflammation
43. Role of adenosine receptors in the control of enteric neuromuscular functions under normal conditions and in the presence of bowel inflammation
44. Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models
45. Enteric Dysfunctions in Experimental Parkinsons Disease: Alterations of Excitatory Cholinergic Neurotransmission Regulating Colonic Motility in Rats
46. Rosuvastatin Prevents Angiotensin II-Induced Vascular Changes by Inhibition of Nad(P)H Oxidase and Cyclooxygenase-1
47. Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by transforming growth factor beta in experimental colitis
48. Alterations of colonic cholinergic and tachykininergic motility in a rat model of Parkinson’s Disease
49. Role of A2B receptors in the control of colonic cholinergic motility in the presence of bowel inflammation
50. Altered adenosine signalling in the presence of bowel inflammation: role of A2B receptors in the control of dolonic motility
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.